title: Safety of dipyridamole testing in patients with cerebrovascular disease.
authors.affiliation: Maisonneuve Hospital, Montreal Heart Institute, Canada.
authors.forename: J
authors.initials: J
authors.lastname: Lette
authors.forename: G
authors.initials: G
authors.lastname: Carini
authors.forename: J L
authors.initials: JL
authors.lastname: Tatum
authors.forename: N
authors.initials: N
authors.lastname: Paquet
authors.forename: G
authors.initials: G
authors.lastname: Bisson
authors.forename: M
authors.initials: M
authors.lastname: Picard
authors.forename: H S
authors.initials: HS
authors.lastname: Bom
authors.forename: A M
authors.initials: AM
authors.lastname: Lusa
authors.forename: G
authors.initials: G
authors.lastname: Labanti
authors.forename: J
authors.initials: J
authors.lastname: Teitelbaum
mesh_terms: D000368:Aged; D002561:Cerebrovascular Disorders / Q000175:diagnosis* / Q000503:physiopathology; D004176:Dipyridamole / Q000009:adverse effects* / Q000494:pharmacology; D005260:Female; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D002546:Ischemic Attack, Transient / Q000139:chemically induced* / Q000503:physiopathology; D008297:Male; D008875:Middle Aged
chemical_list: D004176:Dipyridamole